Sign up for our complimentary
weekly e-journal

Main Newsletter
Mastery Series
Therapy Series
 
Bookmark and Share | Print Article | Disasters Averted Previous | All Articles This Week | Next
This article originally posted 22 August, 2011 and appeared in  Safety and Error PreventionDiabetes Clinical Mastery Series Issue 47Prescription Errors

Diabetes Disaster Averted #47: Mixed Insulin Dosages Lost in Translation

I work in a large teaching hospital in the Northeast and recently had an order written for mixed insulin for a new admission that seemed very odd. One of our newer residents wrote an order for Humalog 75/25: give 9 units at breakfast, 7 units at lunch and 13 units at dinner. I thought for sure that using this 3 times a day, especially at the high dosage at dinner would lead to severe hypoglycemia....

Advertisement

I questioned the resident and he informed me that this was a very common protocol when he was a student. He recommended that I ask the pharmacist about the action curves if I had any questions.

The pharmacist agreed with me and called the resident to get more information. A couple of hours later the pharmacist called me back to give me a new dosage regimen. After the conversation with the resident the dose was changed to Humalog 75/25 18 units at breakfast and 11 units at dinner.

What happened:

When the pharmacist called the resident and discussed the dosing, it came out that the resident had gone to school in Germany and their mixed insulin is short acting first and long acting second, just the opposite of how it is written in the US. So when he ordered 75/25 he was expecting 75% short acting and 25% long acting which would have made sense.

Lesson learned:

Many of our physicians have been trained in other countries where other percent mixtures of insulin are available and so it is important that when we see an odd dose of mixed insulin we verify which one is the long acting component and which is the short acting.

Angie Stubenhoffer, RN
Plainfield, NH

Report Medication Errors to ISMP:

Diabetes in Control is partnered with the Institute for Safe Medication Practices (ISMP) to help ensure errors and near-miss events get reported and shared with millions of health care practitioners. The ISMP is a Patient Safety Organization obligated by law to maintain the anonymity of anyone involved, as well as omitting or changing contextual details for that purpose. Help save lives and protect patients and colleagues by confidentially reporting errors to the ISMP.

Report_Now

*****

And if you have a "Diabetes Disaster Averted" story, please also send it in separately to Diabetes In Control. If we use it you will receive a Visa Gift Card worth $50.00. Click here to let us know the details. (You can use your name or remain anonymous if you prefer.) Please note that ISMP is not associated with this Gift Card promotion.

For more Diabetes Disasters Averted, just follow this link.

Copyright © 2011 Diabetes In Control, Inc.

 

Advertisement


 

Bookmark and Share | Print | Category | Home

This article originally posted 22 August, 2011 and appeared in  Safety and Error PreventionDiabetes Clinical Mastery Series Issue 47Prescription Errors

Past five issues: Diabetes Clinical Mastery Series Issue 85 | Issue 626 | Special Edition - Getting Patients on Track | Diabetes Clinical Mastery Series Issue 84 | Issue 625 |

 
Diabetes In Control Advertisers
 
 
Cast Your Vote
Now that once-weekly GLP-1 is available, which product are you recommending for your type 2 patients?

Navigate Diabetes In Control
Announcement:
Search Articles On Diabetes In Control